PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-12-04

Date Title Company
04-Dec-2024 Real Endpoints Named a Fierce Healthcare Innovation Awards Winner in the Financial/Operational Solutions Category Newswire
04-Dec-2024 Almirall launches The Hive, creating a novel collaborative innovation hub to advance life sciences and healthcare Almirall
04-Dec-2024 Celerion Pledges Commitment to the Science Based Targets Initiative (SBTi) Net-Zero Standard Celerion
04-Dec-2024 Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy Everest Medicines Limited
04-Dec-2024 Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers Tiziana Life Sciences
04-Dec-2024 Elsevier adds 43 million Enamine make-on-demand compounds to Reaxys to accelerate chemistry R&D Elsevier
04-Dec-2024 VR key to training for advanced medicines manufacturing skills, says leading academic RESILIENCE
04-Dec-2024 From Patient Care to Planet Care: How IHH Healthcare is Redefining Healthcare Sustainability IHH Healthcare
04-Dec-2024 VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities VIVEbiotech
04-Dec-2024 Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications Synaffix
04-Dec-2024 Antag Therapeutics Announces €80 Million Series A Financing Antag Therapeutics
04-Dec-2024 European HealthTech Innovation Needs a Lifeline – Join the Conversation to Drive Change European HealthTech
04-Dec-2024 miDiagnostics Secures €30 Million Series D Funding Round Led by Thermo Fisher Scientific to Advance an Innovative Sterility Test and Other Quality Control Tests for use in the BioPharma Industry miDiagnostics
04-Dec-2024 Refoxy Pharmaceuticals raises €9.1 million to progress its novel FOXO3 therapeutics for Idiopathic Pulmonary Fibrosis Refoxy Pharmaceuticals
04-Dec-2024 Capital Increase in Genmab as a Result of Employee Warrant Exercise Genmab
04-Dec-2024 MHRA Grants Marketing Authorisation for LEO Pharma’s Anzupgo® ▼(delgocitinib) cream in Great Britain LEO Pharma
04-Dec-2024 Beckman Coulter Life Sciences Accelerates Drug Discovery with Launch of Cydem VT Automated Clone Screening System Beckman Coulter Life Sciences
04-Dec-2024 Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial Teva Pharmaceutical Industries Ltd
04-Dec-2024 Next-level efficiency and sustainability: SCHOTT Pharma unveils innovative nest design for ready-to-use cartridges SCHOTT Pharma AG & Co. KGaA
04-Dec-2024 Thermosome Initiates Final Dose Level in Phase I Trial of Lead Compound THE001 Thermosome